Bone Microenvironment Changes in Latexin Expression Promote Chemoresistance

This study suggests that the LXN pathway should be further explored as a viable target for preventing or reversing taxane resistance in prostate cancer. Mol Cancer Res; 15(4); 457–66. ©2017 AACR.

Source: Molecular Cancer Research - April 2, 2017 Category: Cancer & Oncology Authors: Zhang, M., Osisami, M., Dai, J., Keller, J. M., Escara-Wilke, J., Mizokami, A., Keller, E. T. Tags: Oncogenes and Tumor Suppressors Source Type: research